Research strategy focuses on cancer evolution
Researchers at the ICR and The Royal Marsden are planning to create a new generation of ‘anti-evolution’ therapies designed to combat cancer’s ability to adapt and resist treatment, as part of their new joint research strategy

Share this article
Our biggest challenge is cancer evolution and drug resistance